研究成果
年分
作者
期刊
研究名稱
2022
Tsai TY, Hsu PF*, Wu CH, Huang SS, Chan WL, Lin SJ, Chen JW, Lu TM, Leu HB.
Nutrients. 2022; 14 (15):3163. (IF: 6.706)
Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores.
2022
Tsai TY, Leu HB, Hsu PF, Yang YL, Chen SC, Huang SS, Chan WL, Lin SJ, Chen JW, Pan JP, Charng MJ, Chen YH, Wu TC, Lu TM, Huang PH, Cheng HM, Huang CC, Sung SH, Lin YJ, Wu CH*.
J. Clin. Hypertens. 2022; 24(10): 1327-1338. (IF: 2.885)
Association between visit-to-visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention.
2022
Tsai YC, Tsao YP, Huang CJ, Tai YH, Su YC, Chiang CE, Sung SH, Chen CH, Cheng HM*.
J. Clin. Hypertens. 2022; 24(9): 1147-1160. (IF: 2.885)
Effectiveness of salt substitute on cardiovascular outcomes: A systematic review and meta-analysis.
2022
Tsai YL, Chou RH, Lu YW, Chang CC, Kuo CS, Huang PH*, Chen JW, Lin SJ.
J. Cardiol. 2022; 79(3): 371-375. (IF: 3.115)
Associations between galectin-1, left ventricular diastolic dysfunction, and heart failure with preserved ejection fraction.
2022
Tung R, Xue YM, Chen ML, Jiang CY, Shatz DY, Besser S, Hu HD, Chung FP, Nakahara S, Kim YH, Satomi K, Shen LS, Liang EP, Liao HT, Gu K, Jiang RH, Jiang J, Hori Y, Choi JI, Ueda A, Komatsu Y, Kazawa S, Soejima K, Chen SA, Nogami A, Yao Y*.
Circulation. 2022; 145(25): 1839-1849. (IF: 39.922)
First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
2022
van Geuns RJ*, Chang CC, McEntegart MB, Merkulov E, Kretov E, Lesiak M, O'Kane P, Hanratty CG, Bressollette E, Silvestri M, Wlodarczak A, Barragan P, Anderson R,Protopopov A, Peace A, Menown I, Rocchiccioli P, Onuma Y, Oldroyd KG.
EuroIntervention. 2022; 17(18): 1467-1476. (IF:7.728)
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.
2022
Wang CY, Hung GU, Lo HC, Tsai SC, He Z, Zhang XW, Chiang KF, Zou JG, Zhou WH, Huang JL*, Chen SA.
J. Nucl. Cardiol. 2022; 29(5): 2571-2579. (IF: 3.872)
Clinical impacts of scar reduction on gated myocardial perfusion SPECT after cardiac resynchronization therapy.
2022
Wang SC, Wang XY, Liu CT, Chou RH, Chen ZB*, Huang PH*, Lin SJ.
Int. J. Mol. Sci. 2022; 23(6):3065. (IF: 6.208)
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates Endothelial Inflammation and Microvascular Thrombosis in a Sepsis Mouse Model.
2022
Wang TD*, Chiang CE, Chao TH, Cheng HM, Wu YW, Wu YJ, Lin YH, Chen MYC, Ueng KC, Chang WT, Lee YH, Wang YC, Chu PH, Chao TF, Kao HL, Hou CLY, Lin TH.
Acta Cardiol. Sin. 2022; 38(3): 225-325. (IF: 1.800)
2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
2022
Wen YW, Wang IT, Hu YT, Cheng HM, Cheng KW, Shiu MN*, Tsa YW*.
Prev. Med. 2022; 161:107091. (IF:4.637)
Duration of varenicline prescription and efficacy of smoking cessation treatment: an observational study in Taiwan.